Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Biomarkers of Metabolic Liver Disease 1.1

NCT04828551 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04828551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04828551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Biomarkers of Metabolic Liver Disease 1.1
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 18, 2021
Completion date
November 20, 2021
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver, nonalcoholic steatohepatitis